Shirou Itagaki

In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid

Yuki Sato, Shirou Itagaki, Toshimitsu Kurokawa et al. · International Journal of Pharmaceutics · 2010 · 956 citations · Full text

Life Sciences, Food Science, Pharmacology +16

Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2)

Sonne R. Srinivas, Elangovan Gopal, Lina Zhuang et al. · Biochemical Journal · 2005 · 142 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Inhibitory effects of statins on human monocarboxylate transporter 4

Masaki Kobayashi, Yukio Otsuka, Shirou Itagaki et al. · International Journal of Pharmaceutics · 2006 · 78 citations

Medicine, Biochemistry, Pharmacology +8

Association between risk of myopathy and cholesterol-lowering effect: A comparison of all statins

Masaki Kobayashi, Ikumi Chisaki, Katsuya Narumi et al. · Life Sciences · 2008 · 64 citations

Medicine, Health Sciences, Pharmacotherapy +12

Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells

Takeshi Hirano, Satoru Yasuda, Yuki Osaka et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2006 · 59 citations

Medicine, Pharmaceutics, Pharmacology +12